Abstract: In order to provide a power supply device having a high rigidity and a light weight, power supply device includes: one or more cell stacked bodies each formed by stacking secondary battery cells; a circuit board including a control circuit electrically connected to the cell stacked bodies; resin-made battery case for storing the cell stacked bodies and circuit board; metal-made lower frame for covering the bottom surface of battery case; and metal-made upper frame for covering the upper surface of battery case. Battery case has a waterproof structure. Battery case is grasped by connecting upper frame to lower frame.

Abstract: The power supply device includes a plurality of battery cells each having a rectangular outer shape; separators each interposed between the battery cells and insulating mutually adjacent battery cells; and fastening members for fastening a battery cell stack including the alternately stacked battery cells and the separators. The separator includes a sandwiching plate portion disposed between the facing principal surfaces of the mutually adjacent battery cells, and a plate-like bottom-surface cover portion provided to both surfaces of the sandwiching plate portion, at a lower end of the sandwiching plate portion, and protruding in a stacked direction of the battery cells to cover bottom surfaces of the battery cells. The bottom-surface cover portions of the separators stacked on both surfaces of the battery cells are stacked on each other at the bottom surfaces of the battery cells.

Abstract: In order to provide a power supply device having a high rigidity and a light weight, power supply device includes: one or more cell stacked bodies each formed by stacking secondary battery cells; a circuit board including a control circuit electrically connected to the cell stacked bodies; resin-made battery case for storing the cell stacked bodies and circuit board; metal-made lower frame for covering the bottom surface of battery case; and metal-made upper frame for covering the upper surface of battery case. Battery case has a waterproof structure. Battery case is grasped by connecting upper frame to lower frame.

Abstract: A wearable apparatus includes a flexible display device, and a flexible housing that holds the peripheral portion of the flexible display device. The flexible display device is disposed on the uppermost surface of the apparatus to serve as a reference for defining the total length of the apparatus, and the portion of the apparatus below the flexible display device contracts along the direction of the total length.

Abstract: A wearable apparatus includes a flexible display device, and a flexible housing that holds the peripheral portion of the flexible display device. The flexible display device is disposed on the uppermost surface of the apparatus to serve as a reference for defining the total length of the apparatus, and the portion of the apparatus below the flexible display device contracts along the direction of the total length.

Abstract: It is an object of the present invention to provide a method for producing an 11-sugar sialylglycopeptide easily and with good yield and a high degree of purity on an industrial scale from defatted bird egg yolks. The present invention provides a production method of an 11-sugar sialylglycopeptide. More specifically, the present invention provides a production method of an 11-sugar sialylglycopeptide comprising: an extraction step of extracting defatted bird egg yolks with water or a salt solution to obtain a liquid extract of a glycopeptide, a precipitation step of adding the liquid extract to a water-soluble organic solvent to precipitate the glycopeptide, and a desalting step of desalting the precipitate.

Abstract: It is an object of the present invention to provide a method for producing an 11-sugar sialylglycopeptide easily and with good yield and a high degree of purity on an industrial scale from defatted bird egg yolks. The present invention provides a production method of an 11-sugar sialylglycopeptide. More specifically, the present invention provides a production method of an 11-sugar sialylglycopeptide comprising: an extraction step of extracting defatted bird egg yolks with water or a salt solution to obtain a liquid extract of a glycopeptide, a precipitation step of adding the liquid extract to a water-soluble organic solvent to precipitate the glycopeptide, and a desalting step of desalting the precipitate.

Abstract: A curable liquid resin optical fiber coating composition comprising 0.1 to 10 wt %, relative to the total weight of the composition, of an alkoxysilane compound (A) which does not contain a radically polymerizable functional group, and 0.01 to 1 wt %, relative to the total weight of the composition, of a hindered amine compound (B). This curable liquid resin composition produces a cured product that ensures a high n-value of the coated optical fiber and an excellent fiber strength after coating removal.

Abstract: A body fluid compatible and biocompatible resin for use in a medical treatment involving a contact of said resin with at least one member selected from the group consisting of a body fluid and a biological tissue, which comprises at least one substituted oxyalkylene polymer having a weight average molecular weight of from 1,000 to 1,000,000 and represented by the following formula (1): wherein each of R1, R2 and R3 independently represents a hydrogen atom or a —CH2R4 group, and each R4 independently represents a hydroxyl group or a —OR5 group (wherein R5 represents a group selected from the group consisting of a C1-C10 aliphatic hydrocarbyl group, a C6-C10 aryl group, a —R6COOH group and a derivative thereof, and a —CH2—O—CH2—CH(OH)—CH2—OR7 group, wherein R6 represents a C1-C10 aliphatic hydrocarbylene group and R7 represents a C1-C10 aliphatic hydrocarbyl group or a C6-C10 aryl group), provided that all of R1, R2, and R3 are not simultaneously hydrogen atoms; and 10?x?10,000 and 0?y?10,000.

Abstract: It is provided for a resin composition including (A) at least one polyamic acid having the structure represented by the following formula (1): wherein R1 is independently an alkyl group having 1 to 3 carbon atoms or a cyano group; a is independently an integer of 0 to 4; R is a tetravalent organic group; n is an integer of 1 to 4; and m is an integer of 1 to 100,000, and (E) an organic solvent.

Abstract: It is provided for a resin composition including (A) at least one polyamic acid having the structure represented by the following formula (1): wherein R1 is independently an alkyl group having 1 to 3 carbon atoms or a cyano group; a is independently an integer of 0 to 4; R is a tetravalent organic group; n is an integer of 1 to 4; and m is an integer of 1 to 100,000, and (E) an organic solvent.

Abstract: A curable liquid resin optical fiber coating composition comprising 0.1 to 10 wt %, relative to the total weight of the composition, of an alkoxysilane compound (A) which does not contain a radically polymerizable functional group, and 0.01 to 1 wt %, relative to the total weight of the composition, of a hindered amine compound. (B). This curable liquid resin composition produces a cured product that ensures a high n-value of the coated optical fiber and an excellent fiber strength after coating removal.

Abstract: It is provided for a resin composition including (A) at least one polyamic acid having the structure represented by the following formula (1): wherein R1 is independently an alkyl group having 1 to 3 carbon atoms or a cyano group; a is independently an integer of 0 to 4; R is a tetravalent organic group; n is an integer of 1 to 4; and m is an integer of 1 to 100,000, and (E) an organic solvent.

Abstract: A body fluid compatible and biocompatible resin for use in a medical treatment involving a contact of said resin with at least one member selected from the group consisting of a body fluid and a biological tissue, which comprises at least one substituted oxyalkylene polymer having a weight average molecular weight of from 1,000 to 1,000,000 and represented by the following formula (1): wherein each of R1, R2 and R3 independently represents a hydrogen atom or a —CH2R4 group, and each R4 independently represents a hydroxyl group or a —OR5 group (wherein R5 represents a group selected from the group consisting of a C1-C10 aliphatic hydrocarbyl group, a C6-C10 aryl group, a —R6COOH group and a derivative thereof, and a —CH2—O—CH2—CH(OH)—CH2—OR7 group, wherein R6 represents a C1-C10 aliphatic hydrocarbylene group and R7 represents a C1-C10 aliphatic hydrocarbyl group or a C6-C10 aryl group), provided that all of R1, R2, and R3 are not simultaneously hydrogen atoms; and 10?x?10,000 and 0?y?10,000.

Abstract: Disclosed is a drug complex of a drug having a hydroxyl group, which is capable of controlling the rate of the release of the drug therefrom in blood, the drug complex being represented by the following formula (1): A—B—C  (1) wherein A represents at least one carrier selected from the group consisting of saccharides each having a carboxyl group, polyethylene glycols each having a carboxyl group, aliphatic carboxylic acids each having a carboxyl group, and derivatives thereof each having a carboxyl group; B represents at least one spacer comprised of a compound having a amino group and a carboxyl group; C represents at least one drug having a hydroxyl group, wherein the carrier A is bonded to the spacer B through an amide bond formed between the carboxyl group of the carrier A and the amino group of the spacer B; and the spacer B is bonded to the drug C through an ester bond formed between the carboxyl group of the spacer B and the hydroxyl group of the drug C.

Abstract: A drug formulation for producing sustained therapeutic efficacy, which releases at least one water-soluble drug over a prolonged period of time at a substantially constant rate wherein said drug formulation comprises(a) a nondisintegrating inner layer comprised of a biocompatible material that contains at least one uniformly dispersed water-soluble drug; and(b) an outer layer comprised of a biocompatible material that surrounds the circumference of the said inner layer, is impermeable to water, and is capable of controlling the swelling of the inner layer; wherein the ratio of the axial length of the drug formulation to the cross-sectional diameter of the inner layer is one or more and wherein one or both ends of the inner layer are open so as to come into direct contact with the external environment.

Abstract: A novel polysaccharide derivative, a drug carrier comprising a novel polysaccharide derivative, and a drug complex are disclosed. The polysaccharide derivative according to the present invention comprises a polysaccharide having a carboxyl group in which a peptide chain is introduced at a part or all of the carboxyl groups of the polysaccharide. The peptide chain comprises 1-8 amino acids which may be the same or different. A part or all of the amino groups in the peptide chain which are not involved in the linkages with the carboxyl groups of the polysaccharide or the carboxyl groups in the peptide chain may form an acid amide linkage or an ester linkage with a carboxyl group, an amino group or a hydroxyl group of a third compound such as drugs. The polysaccharide derivative has a property of accumulating in a high amount at a tumor, and thus can deliver efficiently a drug which has a side-effect or a limited sustainment of the drug efficacy to the tumor.

Abstract: A pharmaceutical composition and its use in the treatment of cerebral edema are provided wherein the composition comprises an atrial natriuretic peptide having an amino acid sequence of 28 amino acids and at least one pharmaceutically acceptable carrier, diluent or excipient.

Abstract: An abrasing apparatus including an annular barrel having an upper opening. The barrel is rotated around an exciting coil and is filled with magnetic abrasive powder which is arranged by magnetic flux generated by the exciting coil to form magnetic brush. A work is embedded into the magnetic brush. The work is rotated together with a spindle and the barrel is rotated so that the surface of the work is abrased by the magnetic brush. A bottom magnetic pole, a lateral magnetic pole and an upper magnetic pole are disposed in an inner periphery in the barrel in the proximity to the exciting coil and the strong magnetic brush is locally formed therein. The side portion of the work is located in the local magnetic brush, and the bottom, side and upper surfaces of the work are abrased like a mirror surface.

Abstract: Residue of distillation, preferably under reduced pressure of oil sand bitumen is thermally treated in a liquid state at a temperature of 350.degree.-450.degree. C. by blowing thereinto an inert heating medium, preferably a superheated steam at a temperature of not lower than the temperature of the residue in a reaction step for 20 to 90 min to crack the residue for converting the residue to a crude synthetic oil, a combustible pitch and a gas, the resultant pitch being utilized to the steps of recovery of oil sand bitumen from oil sand and of distillation as fuel.